Skip to main content

Table 1 Baseline characteristics of the communities and participants (2016, Unnan City)

From: Two-year scale-up dissemination study of a multi-strategic community-wide intervention promoting physical activity: a single-arm pre-post hybrid effectiveness-implementation trial

 

Entire city

High dose groupa

Low dose groupa

Community

29

10

19

Residents, n

40,372

21,246

19,126

Residents aged 40–79 years, n

20,830

10,940

9890

Population density, mean (SD), /km2

73.0

135.6

48.2

Evaluation participations (eligible response rate)

3718/7000 (53.0%)

1960/3847 (50.9%)

1758/3153 (55.8%)

Male

1776 (47.8%)

923 (47.1%)

853 (48.5%)

Age, mean (SD), years

62.0 (10.2)

61.7 (10.4)

62.3 (10.0)

40–59 years

1370 (36.8%)

722 (36.8%)

648 (36.9%)

60–79 years

2348 (63.2%)

1238 (63.2%)

1110 (63.1%)

Body mass index, mean (SD), kg/m2

22.5 (3.1)

22.6 (3.1)

22.5 (3.2)

 < 18.5

285 (7.8%)

153 (7.9%)

132 (7.6%)

≧18.5, < 25

2683 (73.1%)

1405 (72.6%)

1278 (73.7%)

≧25

701 (19.1%)

377 (19.5%)

324 (18.7%)

Self-rated health

Excellent/good

3130 (86.2%)

1639 (85.6%)

1491 (86.8%)

Fair/poor

501 (13.8%)

275 (14.4%)

226 (13.2%)

Years of education, mean (SD)

12.0 (2.3)

12.2 (2.3)

11.7 (2.3)

Employed

2402 (66.1%)

1249 (65.0%)

1153 (67.4%)

Engagement in farming

1880 (51.8%)

849 (44.7%)

1031 (59.6%)

Chronic disease historyb

2209 (59.4%)

1170 (59.7%)

1039 (59.1%)

  1. SD standard deviation. Figures are n (%), n/N (%) or mean (SD) before imputation of missing values unless stated otherwise. Sample sizes (denominators) vary due to missing values
  2. aHigh dose group: top ten communities in the implementation score, based on the naturally differing intervention doses across 29 intervention communities. Low dose group: bottom 19 communities. The details of the implementation score are described in Appendix Tables 1 and 2
  3. bHaving the following disease history: hypertension, hyperlipidemia, diabetes, hyperuricemia, cerebrovascular disease, heart disease, kidney and urologic diseases, liver disease, gastrointestinal disease, endocrine disease, cancer